Skip to main content
. 2020 Dec 22;13(4):491–498. doi: 10.3233/PRM-200724

Table 1.

Clinical questions that informed the bowel function and care guidelines

Age group (from guidelines) Clinical questions
0–11 months
  • What evidence exists that prevention of constipation in the first year of life improves outcome of bowel management in later childhood?
1–2 years 11 months
  • Is there evidence to support the benefit of toilet training a child with Spina Bifida at the same developmental stage as peers without dysfunction?
3–5 years 11 months
  • Is there evidence that “habit training,” or forced evacuation with stimulants, such as suppositories or enemas, increases social continence?
6–12 years 11 months
  • What is the evidence that the MACE (Malone antegrade continence enema) procedure or continent cecostomy is an effective form of bowel management in children with refractory incontinence?
  • What are the most effective protocols for MACE (ACE) management?
  • What is the evidence that electrical stimulation (sacral nerve or intravesicular) provides benefit for increased bowel continence?
13–17 years 11 months
  • What support is needed by young adults with Spina Bifida to be successful in maintaining their bowel program?
  • Is there evidence that hormonal fluctuations impact continence?
18+ years
  • What impact does pregnancy have on bowel management or on use of a cecostomy or MACE? (Women’s Health Guidelines)
  • Does early chronic constipation impact management of constipation in adult years?
  • Is there a change in bowel function later in life that should be addressed with a more aggressive bowel program? Does menopause result in changes?